ePrints

Use of thyroid hormones in hypothyroid and euthyroid patients. A THESIS questionnaire survey of Hungarian physiciansPajzsmirigyhormon-kezelési szokások Magyarországon. A THESIS kérdoíves felmérés eredményei

Lookup NU author(s): Dr Petros PerrosORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Abstract

© Szerzo(k)/The Author(s) 2022. Introduction: Hypothyroidism has a high prevalence in the adult population. Levothyroxine (LT4) supplementation is considered to be the gold-standard treatment method. In Hungary, LT4 tablets and soft gel capsules are the available formulations. Similarly to the international trends, hypothyroidism is earlier recognised, leading to early LT4 supplementation. Up till now, there has been no survey on the treatment of hypothyroidism among Hungarian endocrinologists. Objective: THESIS (Treatment of Hypothyroidism in Europe by Specialists: an International Survey) had been conducted to assess treatment preferences among European endocrinologists. Here we report the results on the use of thyroid hormones in hypothyroid patients and euthyroid individuals in Hungary. Method: An e-mail invitation to participate, containing the link to the online survey was sent to members of the Hungarian Society for Endocrinology and Metabolism. Results: There were 165 responses with full demographics which were included in the analysis. By the majority (99.4%) of them, LT4 was the first treatment of choice. LT4 + LT3 combination was considered an option in patients with persistent symptoms despite biochemical euthyroidism while on LT4 (36,1%). In euthyroid individuals, 60.3% of the respondents would consider starting LT4 in euthyroid infertile women with high antibody levels, which is hardly supported by evidence. In the presence of comorbidities and interfering medications which may hinder LT4 absorption, 66.4% of Hungarian endocrinologist anticipate significant improvement after switching from tablets to soft gel capsules. Conclusion: The treatment of choice for hypothyroidism is LT4 in Hungary. Combination therapy with LT4 + LT3 was considered for patients with persistent symptoms. In the presence of diseases and interfering medications affecting bioavailability, a high number of Hungarian endocrinologists prefer the new LT4 formulation. The administration of LT4 in euthyroid conditions awaits explanation and calls for intensive discussions at local conferences and courses.

Publication metadata

Author(s): Berta E, Lengyel IM, Hegedus L, Papini E, Perros P, Negro R, Attanasio R, Nagy VE, Bodor M

Publication type: Article

Publication status: Published

Journal: Orvosi Hetilap

Year: 2022

Volume: 163

Issue: 12

Pages: 463-472

Online publication date: 20/03/2022

Acceptance date: 13/11/2021

Date deposited: 19/04/2022

ISSN (print): 0030-6002

ISSN (electronic): 1788-6120

Publisher: Akademiai Kiado ZRt.

URL: https://akjournals.com/view/journals/650/163/12/article-p463.xml

DOI: 10.1556/650.2022.32412

PubMed id: 35306479

Altmetrics

Share